Delivery Order SPE2DB24D2100-SPE2DB25FBDLA
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$4.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,349.47, is a delivery order for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a specialty medication. The contract has an ultimate completion date of November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,122.55 firm fixed-price delivery order is for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM, a pharmaceutical product. The contract has an ultimate completion date of March 28, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of a pharmaceutical product - QNASL 80 MCG NASAL SPRAY 10.6GM. The contract, valued at $2,055.12, is a firm fixed-price delivery order with a completion date of November 12, 2024. The award does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery...
This federal contract award, valued at $18,911.47, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The award is for the delivery of QNASL 80 MCG NASAL SPRAY 10.6GM, a pharmaceutical product. The contract does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, with ID SPE2DB20D2001|SPE2DB25FPMNR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,592.25 firm fixed-price delivery order is for the supply of 4568060867 QNASL 80 MCG NASAL SPRAY 10.6GM. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX,...
This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMMDW, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,524.25 firm-fixed-price delivery order is for the supply of QNASL 80 MCG NASAL SPRAY 10.6GM to support military healthcare programs. The contract has an ultimate completion date of March 31, 2025 and was awarded on March 28, 2025. There is no set-aside designation for this...
This $1,717.61 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) on June 12, 2024. The order is for the supply of 4564885519 QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product, with a completion date of June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,242.96, is for the supply of QNASL Children's 40 MCG Spray 6.8GM, a pharmaceutical product. The contract is a firm-fixed price arrangement with a completion date of November 22, 2023. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product, with a ceiling value of $1,736.32 and a period of performance through April 18, 2025. This contract is not set-aside and was awarded on a firm fixed-price basis. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The $1,325.92 contract is for the supply of QNASL 80 MCG Nasal Spray 10.6GM, a pharmaceutical product. The award has an ultimate completion date of August 27, 2024. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment...